Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study

被引:0
|
作者
Tubb, Courtney M. [1 ]
Tubb, Marco [1 ]
Hooijer, Jonathan [1 ]
Chomba, Rispah [2 ]
Nel, Jeremy [1 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
关键词
CRE Enterobacterales; CRE colonisation; CRE infection; Antibiotic; Carbapenamase; carbapenem resistance; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BACTEREMIA; MECHANISMS;
D O I
10.4102/sajid.v40i1.687
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Enterobacterales (CRE) are associated with significant morbidity and mortality. Carbapenem-resistant Enterobacterales colonisation is an important prerequisite for infection, and its surveillance is crucial to reduce spread. However, data from South Africa are limited. Objectives: We aimed to determine CRE colonisation prevalence, the incidence of subsequent CRE infections and the risk factors associated with each. Method: We retrospectively reviewed hospital records from 686 patients admitted to a medical high-care ward at a tertiary hospital in Gauteng, South Africa, between October 2019 and May 2022. Patients were grouped by CRE colonisation status on arrival and discharge. Data on comorbidities, indwelling devices and antibiotic exposure were collected. Results: The prevalence of CRE colonisation was 12.4% (95% confidence interval [CI]: 10.1-15.1), with Klebsiella pneumoniae (81.2%) being the most common CRE isolated and OXA-48-like enzymes (94.5%) being the most frequent carbapenemase detected. Risk factors for CRE colonisation on the univariate analysis included exposure to antibiotics (odds ratio [OR]: 2.21; 95% CI: 0.98-4.96, P = 0.048) and presence of a central venous line (OR: 6.33; 95% CI: 1.78-22.46, P = 0.001). Of patients colonised with a CRE, 21.2% subsequently developed a culture-positive infection within 180 days from the initial colonisation result and the majority within 30 days. These infections were mostly CREs (OR: 4.0, 95% CI: 1.3-12.7), and where the infections were CREs, the causative CRE organism and carbapenemase subtype were identical in each case. Conclusion: Our study documented higher CRE prevalence rates than those previously reported from South Africa. Given the association between CRE colonisation and subsequent infection, urgent measures are required to reduce CRE colonisation rates. As the organism and carbapenemase detected in the initial colonisation and subsequent CRE infection were closely related, knowledge of prior CRE colonisation may assist clinicians with antibiotic choice if patients present with an infection within 30 days of CRE colonisation. Contribution: This study reports higher CRE colonization rates in South Africa than previously documented, highlighting the urgent need to reduce colonization. The close genetic link between CRE colonization and subsequent infection suggests that knowledge of prior colonization can guide clinicians in selecting effective antibiotics, particularly for infections occurring within 30 days. These findings support targeted interventions to address the rising CRE threat.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE)
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Ramanathan, Swetha
    Wilson, Geneva
    Poggensee, Linda
    Evans, Martin
    Jones, Makoto M.
    Pfeiffer, Christopher D.
    Klutts, J. Stacey
    Perencevich, Eli
    Rubin, Michael
    Evans, Charlesnika T.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [22] Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort
    Rigatto, Maria Helena
    Ramos, Fabiano
    Barros, Andressa
    Pedroso, Silvia
    Guasso, Isabelli
    Goncalves, Luciana
    Bergo, Pedro
    Zavascki, Alexandre P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (11) : 3118 - 3125
  • [23] Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study
    Zheng, Guanhao
    Cai, Jiaqi
    Deng, Han
    Yang, Haoyu
    Xiong, Wenling
    Chen, Erzhen
    Bai, Hao
    He, Juan
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2024, 13 (01)
  • [24] Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
    Suay-Garcia, Beatriz
    Teresa Perez-Gracia, Maria
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [25] Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
    Goodman, K. E.
    Simner, P. J.
    Tamma, P. D.
    Milstone, A. M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (01) : 95 - 108
  • [26] Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
    Mennini, Francesco Saverio
    Gori, Mario
    Vlachaki, Ioanna
    Fiorentino, Francesca
    La Malfa, Paola
    Urbinati, Duccio
    Andreoni, Massimo
    HEALTH ECONOMICS REVIEW, 2021, 11 (01)
  • [27] Comparative effectiveness of antibiotic therapy for carbapenem-resistant Enterobacterales (CRE) bloodstream infections in hospitalized US veterans
    Wilson, Geneva M.
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Smith, Bridget M.
    Gonzalez, Beverly
    Jones, Makoto
    Schweizer, Marin L.
    Evans, Martin
    Evans, Charlesnika T.
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (05):
  • [28] The CCM Project "Phenotypic and molecular screening methodologies for the detection of colonizations due to carbapenem-resistant Enterobacterales (CRE)"
    Fasciana, Teresa
    Antonelli, Alberto
    Bianco, Gabriele
    Lombardo, Donatella
    Codda, Giulia
    Roscetto, Emanuela
    Perez, Marianna
    Lipari, Dario
    Arrigo, Ignazio
    Galia, Elena
    Tricoli, Maria Rita
    Calvo, Maddalena
    Niccolai, Claudia
    Morecchiato, Fabio
    Errico, Giulia
    Stefani, Stefania
    Cavallo, Rossana
    Marchese, Anna
    Catania, Maria Rosaria
    Ambretti, Simone
    Rossolini, Gian Maria
    Pantosti, Annalisa
    Palamara, Anna Teresa
    Sabbatucci, Michela
    Serra, Nicola
    Giammanco, Anna
    EPIDEMIOLOGIA & PREVENZIONE, 2024, 48 (06):
  • [29] Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy
    Francesco Saverio Mennini
    Mario Gori
    Ioanna Vlachaki
    Francesca Fiorentino
    Paola La Malfa
    Duccio Urbinati
    Massimo Andreoni
    Health Economics Review, 11
  • [30] Epidemiology of Subsequent Carbapenem-Resistant Enterobacterales (CRE) Infection Among Rectal Carriers: A Meta-Analysis of Incidence, Risk Factors and Their Association With Geographic Region and Age
    Wei, Yuhan
    Luo, Huijuan
    Chen, Xia
    Yan, Qun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (05)